Ocuphire Pharma, Inc. (OCUP) Earnings
|
Expand Research on OCUP
| Next EPS Date | 8/9/24 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -46.4% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -11.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/13/23 | Q323 | $0.25 | -$0.22 | +$0.47 | $11.9M | $3.03M | N/A |  | | Details | |
| 8/11/23 | Q223 | -$0.24 | -$0.23 | -$0.01 | $3.67M | $2.43M | N/A | | | Details | |
| 5/15/23 | Q123 | -$0.28 | -$0.16 | -$0.12 | $1.75M | $3.68M | N/A | | | Details | |
| 3/8/24 | Q423 | -$0.21 | -$0.05 | -$0.16 | $1.69M | $5.36M | N/A | | | Details | |
| 11/4/22 | Q322 | -$0.25 | -$0.29 | +$0.04 | $489K | N/A | N/A | | | Details | |
| 8/12/22 | Q222 | -$0.52 | -$0.33 | -$0.19 | $100K | N/A | N/A | | | Details | |
| 3/8/23 | Q422 | N/A | $1.32 | N/A | N/A | $29.45M | N/A | N/A | N/A | ||
| 3/13/23 | Q422 | N/A | $1.32 | N/A | N/A | $29.45M | N/A | N/A | N/A |
